Rezultati - Kent Armeson
- Showing 1 - 19 results of 19
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Acid ceramidase‐mediated production of sphingosine 1‐phosphate promotes prostate cancer invasion through upregulation of cathepsin B od Thomas H. Beckham, Ping Lu, Joseph Cheng, Dan Zhao, Lorianne S. Turner, Xiaoyi Zhang, Stanley Hoffman, Kent Armeson, Angen Liu, Tucker Marrison, Yusuf A. Hannun, Xiang Liu
Izdano 2012Artigo -
10
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer od Antonio Giordano, Yueying Liu, Kent Armeson, Yeonhee Park, Maya Ridinger, Mark G. Erlander, James M. Reuben, Carolyn D. Britten, Christiana S. Kappler, Elizabeth S. Yeh, Stephen P. Ethier
Izdano 2019Artigo -
11
The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer od Robert M. Gemmill, Patrick Nasarre, Joyce Nair-Menon, Federico Cappuzzo, Lorenza Landi, Armida D’Incecco, Hidetaka Uramoto, Takeshi Yoshida, Eric B. Haura, Kent Armeson, Harry A. Drabkin
Izdano 2017Artigo -
12
Using Endobronchial Ultrasound Features to Predict Lymph Node Metastasis in Patients With Lung Cancer od Jessica S. Wang Memoli, Ezzat El-Bayoumi, Nicholas J. Pastis, Nichole T. Tanner, Mario Gómez, John T. Huggins, Georgiana Onicescu, Elizabeth Garrett‐Mayer, Kent Armeson, Katherine K. Taylor, Gerard A. Silvestri
Izdano 2011Artigo -
13
A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD od M. Hanief Sofi, Yongxia Wu, Taylor Ticer, Steven Schutt, David Bastian, Hee-Jin Choi, Linlu Tian, Corey Mealer, Chen Liu, Caroline Westwater, Kent Armeson, Alexander V. Alekseyenko, Xue‐Zhong Yu
Izdano 2021Artigo -
14
A PERK–miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival od Yiwen Bu, Akihiro Yoshida, Nilesh Chitnis, Brian J. Altman, Feven Tameire, Amanda R. Oran, Victoria Gennaro, Kent Armeson, Steven B. McMahon, Gerald Wertheim, Chi V. Dang, Davide Ruggero, Constantinos Koumenis, Serge Y. Fuchs, J. Alan Diehl
Izdano 2017Artigo -
15
Identification of human CD4 <sup>+</sup> T cell populations with distinct antitumor activity od Michelle H. Nelson, Hannah M. Knochelmann, Stefanie R. Bailey, Logan W. Huff, Jacob S. Bowers, Kinga Majchrzak, Megan M. Wyatt, Mark P. Rubinstein, Shikhar Mehrotra, Michael I. Nishimura, Kent Armeson, Paul G. Giresi, Michael J. Zilliox, Hal E. Broxmeyer, Chrystal M. Paulos
Izdano 2020Artigo -
16
Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse od Joseph Cheng, Aiping Bai, Thomas H. Beckham, Sarah Tucker Marrison, C Yount, Katherine Young, Ping Lü, Anne M. Bartlett, Bill X. Wu, Barry J. Keane, Kent Armeson, David T. Marshall, Thomas E. Keane, Michael T. Smith, E. Ellen Jones, Richard R. Drake, Alicja Bielawska, James S. Norris, Xiang Liu
Izdano 2013Artigo -
17
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention od K. Walter, Marvella E. Ford, Mathew J. Gregoski, Rita Kramer, Kendrea D. Knight, Laura Spruill, Lourdes M. Nogueira, Bradley A. Krisanits, Van Phan, Amanda C. La Rue, Michael B. Lilly, Stefan Ambs, King Chan, Tonya F. Turner, Heidi Varner, Shweta Singh, Jaime Uribarri, Elizabeth Garrett‐Mayer, Kent Armeson, Ebony J. Hilton, Mark J. Clair, Marian H. Taylor, Andrea M. Abbott, Victoria J. Findlay, Lindsay L. Peterson, Gayenell Magwood, David P. Turner
Izdano 2018Artigo -
18
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma od Hannah M. Knochelmann, Joshua D. Horton, Sixue Liu, Kent Armeson, John M. Kaczmar, Megan M. Wyatt, Mary S. Richardson, Shirley H. Lomeli, Ying Xiong, Evan M. Graboyes, Eric J. Lentsch, Joshua D. Hornig, Judith M. Skoner, Seth Stalcup, Maria Vittoria Spampinato, Elizabeth Garrett‐Mayer, Elizabeth C. O’Quinn, Cynthia Timmers, Martin J. Romeo, John Wrangle, Matthew R. Young, Mark P. Rubinstein, Terry A. Day, Roger S. Lo, Chrystal M. Paulos, David M. Neskey
Izdano 2021Artigo -
19
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma od Angela J. Yoon, Richard D. Carvajal, Evan M. Graboyes, John M. Kaczmar, William G. Albergotti, Alexandra E. Kejner, Scott H. Troob, Elizabeth Philipone, Jean-Sebastien Anoma, Kent Armeson, Elizabeth G. Hill, Mary S. Richardson, Tina R. Woods, Bhishamjit S. Chera, Farzad Nourollah-Zadeh, Byung Ju Lee, Subramanya Pandruvada, Antonis Kourtidis, Christina Kingsley, Elizabeth C. O’Quinn, Stephanie Mills, V. Craig Jordan, M. Spencer, Danielle Fails, Trevor D. McKee, Mark Zaidi, Alan Brisendine, Sarah Horn, Shikhar Mehrotra, Besim Öğretmen, Jason G. Newman
Izdano 2025Artigo
Iskalna orodja:
Sorodne teme
Medicine
Cancer
Internal medicine
Biology
Genetics
Oncology
Breast cancer
Cancer research
Biochemistry
Cell biology
Gene
Endocrinology
Immunology
Lung cancer
Receptor
Surgery
Apoptosis
Basal cell
Ceramide
Chemistry
Cohort
Confidence interval
Gastroenterology
Neoadjuvant therapy
Pathology
Prostate cancer
Psychology
Sociology
Sphingolipid
Sphingosine